Obesity drugs like Ozempic and Wegovy are seen as major breakthroughs for those with chronic diseases like obesity and ...

President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce ...

Meitheal Pharmaceuticals has gotten federal approval for a new kind of antibiotic for use on hospitalized patients with ...

Known as pre-methylenomycin C lactone, this antibiotic is derived from a model species that’s been studied for nearly 80 ...

President Donald Trump unveiled steep discounts on GLP-1 weight loss drugs in deals with pharmaceutical giants Eli Lilly and ...

A Trump administration deal to cut prices for popular weight-loss drugs like Wegovy and Zepbound will allow millions more ...

Helen Zgurskaya and Valentin Rybenkov, researchers at the University of Oklahoma, are leading a five-year, $5.3 million project funded by the National Institute of Allergy and Infectious Diseases to ...

Novo Nordisk and Eli Lilly said they've agreed to sell their blockbuster drugs Wegovy and Zepbound at a discount.

Florida’s attorney general has filed a lawsuit against Planned Parenthood, claiming the organization is “misrepresenting the ...

Even though nearly all women-approximately 85%-report experiencing menopause symptoms, science has offered very few solutions ...

A White House deal with Eli Lilly & Co. and Novo Nordisk to lower the prices of their popular obesity medicines, Zepbound and ...

The list prices of obesity drugs Wegovy and Zepbound are over $1,000, but that’s not necessarily what you pay.